Wedelolactone Attenuates N-methyl-N-nitrosourea-Induced Retinal Neurodegeneration through Suppression of the AIM2/CASP11 Pathway. (2022)
Attributed to:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/biomedicines10020311
PubMed Identifier: 35203520
Publication URI: http://europepmc.org/abstract/MED/35203520
Type: Journal Article/Review
Volume: 10
Parent Publication: Biomedicines
Issue: 2
ISSN: 2227-9059